P. Reilly

发表

The native structure of intercellular adhesion molecule-1 (ICAM-1) is a dimer. Correlation with binding to LFA-1.

P. Reilly, J. Woska, D. Jeanfavre, 1995, Journal of immunology.

Cutting edge: a small molecule antagonist of LFA-1-mediated cell adhesion.

P. Reilly, J. Woska, D. Jeanfavre, 1999, Journal of immunology.

Effect of deoxycoformycin and Val-boroPro on the associated catalytic activities of lymphocyte CD26 and ecto-adenosine deaminase.

P. Reilly, J. Woska, D. Jeanfavre, 1996, Biochemical pharmacology.

LFA-1-Mediated Cell Adhesion Cutting Edge : A Small Molecule Antagonist Rothlein

P. Reilly, J. Woska, D. Jeanfavre, 1999 .

An orally active, primate selective antagonist of LFA-1 inhibits delayed-type hypersensitivity in a humanized-mouse model.

P. Reilly, D. Jeanfavre, T. A. Kelly, 2006, European journal of pharmacology.

The role of leukocyte function-associated antigen-1 in animal models of inflammation.

P. Reilly, G. Nabozny, M. Panzenbeck, 2001, European journal of pharmacology.

Identification of dissociated non-steroidal glucocorticoid receptor agonists.

J. Proudfoot, P. Reilly, Alison J Kukulka, 2007, Bioorganic & medicinal chemistry letters.

Small molecule LFA-1 antagonists compete with an anti-LFA-1 monoclonal antibody for binding to the CD11a I domain: development of a flow-cytometry-based receptor occupancy assay.

P. Reilly, J. Woska, D. Jeanfavre, 2003, Journal of immunological methods.

Second-generation lymphocyte function-associated antigen-1 inhibitors: 1H-imidazo[1,2-alpha]imidazol-2-one derivatives.

K. Qian, P. Reilly, J. Woska, 2004, Journal of medicinal chemistry.